Molecular Mechanisms of HIV Entry

被引:159
|
作者
Wilen, Craig B. [1 ]
Tilton, John C. [1 ]
Doms, Robert W. [1 ]
机构
[1] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA
来源
VIRAL MOLECULAR MACHINES | 2012年 / 726卷
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN TRIMERS; CCR5; MONOCLONAL-ANTIBODY; DEFICIENCY SYNDROME AIDS; RECOMBINANT SOLUBLE CD4; CHEMOKINE RECEPTOR GENE; AMINO-TERMINAL DOMAIN; DC-SIGN; DISEASE PROGRESSION; TYROSINE SULFATION;
D O I
10.1007/978-1-4614-0980-9_10
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus (HIV) entry is a complex and intricate process that facilitates delivery of the viral genome to the host cell. The only viral surface protein, Envelope (Env), is composed of a trimer of gp120 and gp41 heterodimers. It is essentially a fusion machine cloaked in a shroud of carbohydrate structures and variable loops of amino acids that enable it to evade the humoral immune response. For entry to occur gp120 sequentially engages the host protein CD4 and then one of two chemokine coreceptors, either CCR5 or CXCR4. CD4 binding facilitates exposure and formation of the coreceptor-binding site, and coreceptor binding then triggers the membrane fusion machinery in the gp41 subunit. Our understanding of HIV entry has led to the development of successful small molecule inhibitors for the clinical treatment of HIV infection as well as insights into viral tropism and pathogenesis.
引用
收藏
页码:223 / 242
页数:20
相关论文
共 50 条
  • [1] The molecular basis of HIV entry
    Klasse, Per Johan
    [J]. CELLULAR MICROBIOLOGY, 2012, 14 (08) : 1183 - 1192
  • [2] Resistance to HIV-1 entry inhibitors may occur by multiple molecular mechanisms
    Petropoulos, CJ
    Huang, W
    Toma, J
    Fransen, S
    Bonhoeffer, S
    Whitcomb, JM
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U35 - U35
  • [3] HIV entry into the cells - mechanisms and therapeutic possibilities
    Briz, V
    Poveda, E
    Soriano, V
    [J]. MEDICINA CLINICA, 2006, 126 (09): : 341 - 348
  • [4] HIV - MOLECULAR MECHANISMS
    OVERBAUGH, J
    PAVLAKIS, GN
    [J]. MOLECULAR MEDICINE TODAY, 1995, 1 (02): : 54 - 55
  • [5] Molecular Mechanism of HIV-1 Entry
    Chen, Bing
    [J]. TRENDS IN MICROBIOLOGY, 2019, 27 (10) : 878 - 891
  • [6] HIV entry inhibitors: mechanisms of action and resistance pathways
    Briz, V
    Poveda, E
    Soriano, V
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) : 619 - 627
  • [7] Mechanisms of opsonized HIV entry in normal B lymphocytes
    Legendre, C
    Gras, G
    Krzysiek, R
    Galanaud, P
    Richard, Y
    Dormont, D
    [J]. FEBS LETTERS, 1996, 381 (03) : 227 - 232
  • [8] Understanding mechanisms of HIV-1 entry into cells
    Gorry, Paul R.
    [J]. MICROBIOLOGY AUSTRALIA, 2014, 35 (02) : 99 - 100
  • [9] Molecular and cellular mechanisms for microbial entry into the CNS
    Zhang, JR
    Tuomanen, E
    [J]. JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) : 591 - 603
  • [10] Virus entry: Molecular mechanisms and biomedical applications
    Dimitrov, DS
    [J]. NATURE REVIEWS MICROBIOLOGY, 2004, 2 (02) : 109 - 122